CTSB and Alzheimer disease: Bernstein and Keilhoff recently reviewed the putative roles of cathepsin B in AD pathology and highlighted that it shows a neuroprotective effect by lowering Aβ levels and improving neuronal dysfunction; in contrast, it may also contribute to AD pathology by acting as a β-secretase and generating pyroglutamate Aβ [150].